The Top 5 Analyst Questions From Bruker’s Q4 Earnings Call
1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 That Underwhelm
Bruker’s (NASDAQ:BRKR) Q4 CY2025 Sales Beat Estimates
Q4-25 revenues of $977.2 million, flat year-over-year (yoy), down ~5% organically Q4-25 GAAP diluted earnings per share (EPS) of $0.10; non-GAAP diluted...
At SLAS2026 , Chemspeed Technologies , a leader in the automation and digitalization of R&D and QC laboratories, and SciY , a leader in scientific and laboratory...
New iNTApharma system enables rapid, native‑state size and concentration measurements with single‑particle sensitivity for viral, vesicle, and nanoscale bioparticle workflows
Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors (“Board”) has approved payment of a quarterly cash dividend in the amount of $3.9844 per share on the Company’s...